Pear Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pear Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q4 2022.
  • Pear Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$29.2M, a 14.8% increase year-over-year.
  • Pear Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$123M, a 16.7% decline year-over-year.
  • Pear Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$123M, a 16.7% decline from 2021.
  • Pear Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$106M, a 37.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$123M -$29.2M +$5.07M +14.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$128M -$26.6M +$1.72M +6.07% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$130M -$32.8M -$10.9M -49.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$119M -$34.7M -$13.6M -64.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$106M -$34.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$28.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$21.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$21.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.